WallStreetZenWallStreetZen

NASDAQ: SIBN
Si Bone Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SIBN

Based on 3 analysts offering 12 month price targets for Si Bone Inc

Min Forecast
$20.00+6.44%
Avg Forecast
$22.67+20.63%
Max Forecast
$25.00+33.05%

Should I buy or sell SIBN stock?

Based on 3 analysts offering ratings for Si Bone Inc.

Strong Buy
Strong Buy
3 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although SIBN's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates SIBN as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their SIBN stock forecasts and price targets.

SIBN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-02
lockedlocked$00.00+00.00%2025-10-15
lockedlocked$00.00+00.00%2025-08-05

1 of 1

Forecast return on equity

Is SIBN forecast to generate an efficient return?

Company
N/A
Industry
28.43%
Market
226.45%

Forecast return on assets

Is SIBN forecast to generate an efficient return on assets?

Company
N/A
Industry
13.29%

SIBN earnings per share forecast

What is SIBN's earnings per share in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
-$0.54
Avg 2 year Forecast
-$0.50
Avg 3 year Forecast
-$0.33

SIBN revenue forecast

What is SIBN's revenue in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
$203.0M+4.88%
Avg 2 year Forecast
$234.1M+20.93%
Avg 3 year Forecast
$269.0M+38.96%
SIBN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SIBN revenue growth forecast

How is SIBN forecast to perform vs Medical Devices companies and vs the US market?

Company
11.48%
Industry
7.12%
Market
25.86%
SIBN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SIBN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SIBN vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
SIBN$18.79$22.67+20.63%Strong Buy
BFLY$3.05$3.00-1.64%Buy
CBLL$20.18$18.67-7.50%Strong Buy
PACB$2.37$1.83-22.66%Buy
INMD$14.50$17.67+21.84%Buy
View Top Medical Device Stocks

Si Bone Stock Forecast FAQ

Is Si Bone Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: SIBN) stock is to Strong Buy SIBN stock.

Out of 3 analysts, 3 (100%) are recommending SIBN as a Strong Buy, 0 (0%) are recommending SIBN as a Buy, 0 (0%) are recommending SIBN as a Hold, 0 (0%) are recommending SIBN as a Sell, and 0 (0%) are recommending SIBN as a Strong Sell.

If you're new to stock investing, here's how to buy Si Bone stock.

What is SIBN's earnings growth forecast for 2025-2027?

(NASDAQ: SIBN) Si Bone's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 14.26%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.53%.

Si Bone's earnings in 2025 is -$21,755,000.On average, 11 Wall Street analysts forecast SIBN's earnings for 2025 to be -$23,496,364, with the lowest SIBN earnings forecast at -$23,387,886, and the highest SIBN earnings forecast at -$23,600,503. On average, 11 Wall Street analysts forecast SIBN's earnings for 2026 to be -$21,730,340, with the lowest SIBN earnings forecast at -$25,088,823, and the highest SIBN earnings forecast at -$19,591,151.

In 2027, SIBN is forecast to generate -$14,436,270 in earnings, with the lowest earnings forecast at -$19,560,777 and the highest earnings forecast at -$5,011,690.

What is SIBN's revenue growth forecast for 2025-2027?

(NASDAQ: SIBN) Si Bone's forecast annual revenue growth rate of 11.48% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.12%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.86%.

Si Bone's revenue in 2025 is $193,578,000.On average, 11 Wall Street analysts forecast SIBN's revenue for 2025 to be $8,809,292,387, with the lowest SIBN revenue forecast at $8,432,222,390, and the highest SIBN revenue forecast at $9,084,826,850. On average, 11 Wall Street analysts forecast SIBN's revenue for 2026 to be $10,157,458,649, with the lowest SIBN revenue forecast at $9,717,471,333, and the highest SIBN revenue forecast at $10,501,117,381.

In 2027, SIBN is forecast to generate $11,671,813,413 in revenue, with the lowest revenue forecast at $11,172,813,992 and the highest revenue forecast at $12,076,219,901.

What is SIBN's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: SIBN) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 13.29%.

What is SIBN's Price Target?

According to 3 Wall Street analysts that have issued a 1 year SIBN price target, the average SIBN price target is $22.67, with the highest SIBN stock price forecast at $25.00 and the lowest SIBN stock price forecast at $20.00.

On average, Wall Street analysts predict that Si Bone's share price could reach $22.67 by Dec 2, 2026. The average Si Bone stock price prediction forecasts a potential upside of 20.63% from the current SIBN share price of $18.79.

What is SIBN's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: SIBN) Si Bone's current Earnings Per Share (EPS) is -$0.51. On average, analysts forecast that SIBN's EPS will be -$0.54 for 2025, with the lowest EPS forecast at -$0.54, and the highest EPS forecast at -$0.54. On average, analysts forecast that SIBN's EPS will be -$0.50 for 2026, with the lowest EPS forecast at -$0.58, and the highest EPS forecast at -$0.45. In 2027, SIBN's EPS is forecast to hit -$0.33 (min: -$0.45, max: -$0.12).

What is SIBN's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: SIBN) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.